Halozyme Therapeutics, Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Jun 2010 | 97.4% | -378.2% | -378.1% |
| Sep 2010 | 99.8% | -366.1% | -365.4% |
| Mar 2011 | 99.8% | -128.0% | -127.7% |
| Jun 2011 | 99.2% | 13.4% | 13.4% |
| Sep 2011 | 99.9% | 22.5% | 22.5% |
| Dec 2011 | 97.7% | -764.3% | -763.8% |
| Mar 2012 | 1.6% | -203.5% | -203.2% |
| Jun 2012 | 4.9% | -181.1% | -180.8% |
| Sep 2012 | 9.2% | -375.5% | -375.0% |
| Dec 2012 | 3.7% | -20.2% | -20.2% |
| Mar 2013 | 6.5% | -156.3% | -163.0% |
| Jun 2013 | 12.6% | -153.0% | -158.5% |
| Sep 2013 | 58.3% | -115.5% | -120.5% |
| Dec 2013 | 50.1% | -170.6% | -175.9% |
| Mar 2014 | 25.5% | -210.8% | -221.9% |
| Jun 2014 | 19.4% | -81.3% | -88.5% |
| Sep 2014 | 30.6% | -130.3% | -138.8% |
| Dec 2014 | 13.2% | -12.7% | -17.4% |
| Mar 2015 | 12.2% | -32.7% | -46.6% |
| Jun 2015 | 16.2% | 12.7% | -80.6% |
| Sep 2015 | 13.2% | -73.0% | -90.9% |
| Dec 2015 | 13.9% | 14.0% | -70.2% |
| Mar 2016 | 12.2% | -38.0% | -46.6% |
| Jun 2016 | 16.2% | -65.2% | -80.6% |
| Sep 2016 | 13.2% | -71.4% | -90.9% |
| Dec 2016 | 13.9% | -57.9% | -70.2% |
| Mar 2017 | 13.2% | -93.1% | -111.3% |
| Jun 2017 | 14.8% | -75.5% | -91.1% |
| Sep 2017 | 8.2% | 12.7% | 4.3% |
| Dec 2017 | 2.7% | 66.4% | 65.4% |
| Mar 2018 | 12.1% | -76.8% | -89.0% |
| Jun 2018 | 10.4% | -57.0% | -65.0% |
| Sep 2018 | 22.1% | -99.7% | -109.0% |
| Dec 2018 | 8.4% | -0.1% | -3.5% |
| Mar 2019 | 6.6% | 5.2% | 3.2% |
| Jun 2019 | 9.9% | -35.7% | -37.4% |
| Sep 2019 | 14.9% | -53.1% | -54.1% |
| Dec 2019 | 11.2% | -59.7% | -64.1% |
| Mar 2020 | 9.3% | -12.7% | -24.1% |
| Jun 2020 | 1.1% | 53.5% | 46.8% |
| Sep 2020 | 5.3% | 61.7% | 55.4% |
| Dec 2020 | 5.1% | 63.8% | 60.1% |
| Mar 2021 | 79.5% | 57.0% | 31.3% |
| Jun 2021 | 83.1% | 68.2% | 67.0% |
| Sep 2021 | 84.0% | 65.3% | 187.0% |
| Dec 2021 | 78.8% | 55.4% | 65.5% |
| Mar 2022 | 86.4% | 64.5% | 51.3% |
| Jun 2022 | 77.7% | 22.4% | 14.9% |
| Sep 2022 | 77.4% | 39.9% | 29.5% |
| Dec 2022 | 76.8% | 41.1% | 31.8% |
| Mar 2023 | 78.3% | 33.2% | 24.4% |
| Jun 2023 | 77.3% | 42.7% | 33.8% |
| Sep 2023 | 74.6% | 40.9% | 37.9% |
| Dec 2023 | 77.3% | 43.9% | 37.1% |
| Mar 2024 | 85.5% | 48.8% | 39.2% |
| Jun 2024 | 82.9% | 50.7% | 40.3% |
| Sep 2024 | 83.0% | 56.3% | 47.2% |
| Dec 2024 | 85.9% | 58.9% | 46.0% |
| Mar 2025 | 81.7% | 53.4% | 44.6% |
| Jun 2025 | 85.8% | 62.2% | 50.7% |
| Sep 2025 | 84.4% | 61.5% | 49.5% |
| Dec 2025 | 82.6% | -20.6% | -31.3% |
| Mar 2026 | 79.0% | 49.0% | 39.8% |
| Jun 2026 | 83.5% | 59.8% | 47.8% |